About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
exaly
›
Institutions
›
Royal Hallamshire Hospital
›
Department of Urology
›
Top Articles
Department of Urology
Royal Hallamshire Hospital
828
Articles
18.9K
Citations
2.3
avg. Impact Factor
68
h-index
Most Cited Articles of Department of Urology in 2005
Title
Journal
Year
Citations
A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial
European Urology
2005
257
Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma
Journal of Clinical Oncology
2005
249
The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis
European Urology
2005
182
The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: current concepts and future prospects
BJU International
2005
176
A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder
BJU International
2005
116
The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican
Prostate
2005
80
Prognostic value of serum markers for prostate cancer
Scandinavian Journal of Urology and Nephrology
2005
55
An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence
European Urology
2005
50
Recent advances in basic science for overactive bladder
Current Opinion in Urology
2005
46
Stress incontinence injection therapy: what is best for our patients?
European Urology
2005
41
Comparison of darifenacin and oxybutynin in patients with overactive bladder: assessment of ambulatory urodynamics and impact on salivary flow
European Urology
2005
35
Vesico-vaginal fistula
BJU International
2005
32
A critical review of diagnostic criteria for evaluating patients with symptomatic stress urinary incontinence
BJU International
2005
17
Primer: questionnaires versus urodynamics in the evaluation of lower urinary tract dysfunction-one, both or none?
Nature Reviews Urology
2005
17
The urgency of the problem and the problem of urgency in the overactive bladder
BJU International
2005
14
Towards a better understanding of involuntary detrusor activity
BJU International
2005
14
The Development of the Oral Controlled Absorption System (OCAS®): A New Improved Formulation of Tamsulosin
European Urology Supplements
2005
7
Night Time Symptom Control with Omnic (Tamsulosin) Oral Controlled Absorption System (OCAS®)
European Urology Supplements
2005
7
An evaluation of a telephone follow-up clinic in urology
Journal of Sexual Medicine
2005
5
The Road to Cystectomy: Who, When and Why?
EAU Update Series
2005
4
The Oral Controlled Absorption System (OCAS®): The Evolution of Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)
European Urology Supplements
2005
1
Schools/Departments
The list of schools/departments is not comprehensive since it is common to drop the department in the affiliation.
site/software ©
exaly
; All materials licenced under
CC by-SA
.